Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Wrong - the article cites "BEFORE 2021" not in 2021. Very big important distinction.
"Our FY2021 forecast includes the assumption that the FDA will provide a preliminary and positive direction before 2021 on the regulation of CBD infused dietary supplements. We believe the main considerations impacting the agency's willingness to issue a preliminary update and the timing of such an update are concerns around product safety, counteracted by the massive industry and consumer demand for CBD products and pressure from Congress on providing the industry with clear guidelines on the legality of such products. If and when the FDA were to allow ingestible CBD products, we believe the uptake among F/D/M channels will be significant, and Charlotte's Web is well-positioned to be a leader in the ingestible CBD market."
That's a fake news website pushing a hack CBD brand. There is NO credible evidence anywhere on the web about Tiger Woods and Phil Mickelson teaming up to launch their own CBD brand.
If there is - please post it here. I couldn't find any.
A lot of hack brands do this. They hire firms to make websites that LOOK like a news website to convince people it's a real news article and people get excited about the "news." But in fact it's all just cheap hack marketing.
What's a MAGA board?
I saw it on the board. He was on a panel. Someone linked to an article from whatever conference he was at. Would be hard to find it now I think.
Sorry - just learned the Tiger Woods stuff is fake news being pushed by someone on multiple boards.
Tiger Woods fake CBD news. This is a fake website pushing fake information.
I believed it for a minute too - pretty convincing but nope.
Don't buy into this. This guy posted this on another board too.
THIS IS FAKE NEWS: That is a fake website that is just marketing fake news to get people to buy their hack brand.
FDA walked back their timeline and is non-committal to any timeline they said.
Dowling himself said the other day in a panel that he expects 6-36 months before FDA releases guidelines.
Maybe they release something interim but so far FDA has given no REAL indication they are going to.
I'm long and underwater big in this.
But Tiger Woods and Phil Mickelson teaming up for a CBD/hemp line and Canopy launching their US line...
Both are MUCH better marketers, both have much bigger pockets and both would sell much better on a shelf than CVSI.
This is the first time I'm considering eating my losses and moving on.
There's just no way big chains don't jump at the chance to have Tiger Woods and Phil branded/marketed CBD on their shelves.
And CVSI's lack of consumer marketing and public affairs footprint seems almost incompetent at this point.
Getting deals signed and ONTO shelves is one thing, but marketing to KEEP your shelf space is an entirely other thing.
If I'm CVS, I'm kicking anyone I need to out, to get Tiger/Phil stuff on my shelves.
This means that any company can hire NSF and try to get their stuff certified as 'organic' if it meets their criteria.
Since NSF wants clients to keep paying and to have a long-term relationship - it's an incestuous relationship - just like the bond rating agencies and the big banks.
As industry testing ramps up, it just diminishes CVSI's early lead in testing. Because more and more any brand is going to have easier and easier access to testing.
Just another one of CVSI's competitive advantages being eroded, rapidly.
I think CVSI should try to sell ASAP - here’s why. Sell for a respectable price. $4-$6 because if the FDA takes a while to get it's rules in place (Dowling even said 6-36months) there's just no way that these larger companies entering the US market don't edge out CVSI with their much larger marketing budgets and R&D budgets.
Canopy’s new US line, Tiger Woods & Phil Mickelson’s new line (Their net worth alone dwarf CVSI market cap!) and more.
And anything marketed by Tiger Woods and Phil Mickelson Is going to kick the living sh*t out of CVSI on a shelf.
All of the years of prep work that CVSI has put into their products’ scientific and chemical integrity means nothing when big players get into the market and can easily achieve the same integrity very quickly with larger budgets to pay for quality.
And consumer sales marketing is NOT CVSI’s strong suit.
NEWS: Canopy Growth launches US CBD line
The longer we don't have ingestibles on the shelves of the largest retailers that topicals are already in, the more chance CVSI has to get overtaken and fade away quietly.
https://www.bnnbloomberg.ca/canopy-enters-u-s-consumer-market-with-new-cbd-brand-1.1356601
We need FDA rules ASAP.
Good profile story to start creating a narrative around CVSI. A few notes:
- The story is lacking comparison to how CVSI stacks up against the BS brands out there. I wish it compared and contrasted CVSI to crappy brands to show just how much care CVSI has put into all of this.
- Too bad this wasn't in a bigger news outlet like CNBC.
- But this is a good profile piece to launch to larger platforms to keep telling their story.
It's crazy the whole story isn't actually online, but within an online PDF of a magazine. Get with the digital age already MJ Biz magazine.
What makes you say we are "due for a day up?"
Is this the day we close below $1.00?
If we do, it'll go down quite a bit after that.
"That will easily happen in 2020." - really? There have been a lot of predictions on this board - and the only ones who have been right are the shorts. The longs have been wrong almost EVERY time. To say anything will 'easily happen' for a full half a year - is foolish.
This is the OTC in a regulatory ambiguous industry - NOTHING will "easily happen."
Before you start throwing insults around - you should watch the quality of your own words with such foolish predictions.
It really would be. The more the FDA talks, the more it seems they are going to drag this out.
So either Congress acts (I don't put much stock in this) or we just wait and wither on the vine.
Who knows - we'll see. The government is a cesspool of incompetent bureaucrats so their inaction and slowness to action is predictable I suppose.
If you've ever interacted with the government, you know they are some of the least motivated, complacent, malcontents out there sucking on the taxpayer - content with their cushy little lives inside the beltway - made by us, the taxpayers and industries that make this country go.
Agree with this. CWEB is the industry darling and CVSI sales dropped and CWEB's didn't.
Holding steady and a big drop are vastly different things.
Fingers crossed we don't get hit with a class action for advertising as a "Dietary Supplement."
I'm long with a lot of shares and down a lot.
But remember, first status mover means jack.
Napster was first mover. MySpace was first mover.
CVSI is a few quarters away from being non-existent. If sales continue to slow/decline as they did last quarter they won't be able to hold out to one day get their ingestibles on the big chain store shelves.
I'm hoping for the best and see opportunity - I have no choice right now.
But let's not kid ourselves; this company is a few quarters away from being virtually non-existent.
Pure sales companies ALWAYS are a few quarters away from disappearing. It's a fact of life for pure sales companies. Always has been, always will be.
Even on the homepage of pluscbdoil.com it has a bottle that has "Dietary Supplement."
In fact, all CVSI ingestibles have "Dietary Supplement" plastered at the bottom of their bottles in all caps on every bottle on their website.
Here is a page on their website literally titled: TAKING DIETARY SUPPLEMENTS: PLUSCBD™ OIL
https://pluscbdoil.com/taking-dietary-supplements-plus-cbd-oil/
I mentioned this the other week on this board but no one replied.
Does anyone have any idea how they can still be marketing it this way? It seems they are just waiting to be knocked down by the FDA.
Yes, at a different price point. I like that as well.
Mona leaving as COO - fantastic news.
There is 0 possibility he is qualified as a COO of this company any longer.
We need a COO with larger industry experience from products that are much more successful than PlusCBD oil.
We need a COO who has large scale national sales experience especially because sales is our weak spot.
Product seems to be over-priced
Consumer marketing seems to be weak
Branding seems to be weak
Sales are tanking because they are losing touch with the consumer buying habits around CBD.
Get someone from Tylenol, or a major consumer brand in here ASAP.
100% agree.
You should email that to CVSI directly.
How disappointing.
Yesterday and today remind me of two other OTC companies I was in when price action moved like this.
Cloudy regulatory environment
Hot, very solid company but on OTC so stock manipulation and volatility was rampant
Unexpected run up
One announced a reverse merger of a huge company
The other was acquired
I think any company like them would at least entertain a sale because:
- There is still incredible risk associated with navigating the next 2-5 years
- Their business model is not that complicated and big money competitors can replicate it relatively easily - all CVSI has is a (1.) scrappy, small head start by doing the legwork to get in a few thousand stores that established players can get in a lot easier and (2.) CBD that actually contains as much as its packaging says.
- Depending on the acquisition, shareholders may get shares in the acquiring company, which they then would be able to keep building value if they wanted.
- At some points in time, management, larger shareholders and others feel like it may be time to move on and find their next big venture.
There are some good reasons not to sell too.
I'd be in favor of selling the company as long as it wasn't a ridiculously low valuation.
Good point. Still would have been good to have CVSI on that list showing they are #1 in accuracy, and therefore R&D, controlled supply chain etc.
Irth didn't send the stock price anywhere. The business function of the actual business, growing revenues and one specific breakout quarter moved the stock price. A breakneck explosion of CBD excitement along with farm bill that didn't do what everyone thought it would - helped the SP along as well.
Communications functions within businesses can only talk about what the business does.
If the business does great, good. If the business does bad, like CVSI did last Q, then that's not good. And the air being let out of the Farm Bill this year also didn't help along with nationwide bad press about CBD.
Company comms functions take on the personality of the dominant figures in the C-Suite, usually the CEO.
Joe and the gang are set on performing and showing a calm, steady hand that executes after years of Monas running the show and their volatility and unprofessionalism.
Communication firms do not do anything other than reflect the business performance and the C-Suite psychology.
Stop blaming an outside vendor for stock price. It's not their fault - it's, as always the CEO and industry conditions primarily.
CW fails by 50% in marketing/dosage comparison test. This is quite the lack of quality control from the 'industry leader.'
https://www.leafly.com/news/strains-products/cbd-oil-test-results
I wish they had tested CVSI too though.
You can tell how people trade by how they refer to things. No no, not the stock, the company. The stock is worth what it's worth right now per the price of a share. The actual company is definitely worth more than the stock price and anyone trying to acquire the company will know this.
When acquiring a company, you don't look at the stock, you look at the company fundamentals and IP.
Sure you can use the SP as a negotiating tool, but if negotiations went solely on SP, there would never be any M&A activity ever.
For a relatable example: Think Facebook used WhatsApp's private share price when shelling out $17 billion for it? Nope.
The industry leader is off 50%!?!?!
Unfortunately, if the industry leader is off that much, it will look bad for the whole industry if media picks up on that and runs with it.
That miss means huge potential harm for the industry for the next few months if media wanted to decimate the reputation of CBD.
50 cosponsors isn't a whole lot when it comes to looking like a bill is on its way to passage and law. But it's a step.
Where are you seeing this 'rumor' ? Would love to look into it more.
I'd be 'ok' with a $4.75 buyout. Not extremely happy, but not a loss so that would be good.
And PLEASE don't say you 'saw it on twitter' or 'saw it on another message board' because that would be a waste of your post, time and is silly speculation.
There are multiple other ways that a company can uplist to NASDAQ while under the four dollar trading mark. Two dollars and three dollars if they meet other requirements. Maybe you missed it but those alternate ways have been discussed robustly here.
Considering what the market cap for this company would be at $1.00 it would be absurd to reach $1.00. But it IS the OTC so anything can happen here in the land of manipulators and no regulatory exchange oversight.
If it hits $1.00 I'd be a big buyer again. It's just stupid cheap at that price.
But if it does hit $1.00, it would definitely go lower so I'd be a buyer below that. I'd scoop some up at $1.00 regardless though.
You're right. I'm concerned that some of these smaller brands that are focused on top line revenue like most growth companies can be merged and acquired and then all of a sudden there are a few real competitors to CVSI.
I personally find CVSI's price points questionable when you have so many other lower price points.
I understand that each industry has low and high players, but this isn't automobiles where you can tell immediately the difference between Honda and Benz. Hardly anyone can tell the difference in CBD when there is so much out there.
- You buy a cheap brand b/c CVSI is so expensive.
- The cheap brand doesn't do that well
- You don't buy CBD again
- Or maybe someone tells you about CVSI and you give it a shot but at that point if it's not a huge difference with the cheap brand, they'll never buy it again.
I'm not sure how big of a problem it really is, I'm just bringing up the fact that there is real vulnerability to CVSI at this point and people here assume that just because they have self-GRAS, a few other shiny things, and some cash, that they will automatically survive.
They are at a huge risk of failing and no one should forget that.
I think it would be wise for Dowling to acknowledge that CVSI takes seriously this vulnerable position and they are aggressively taking efforts to mitigate the few key factors that doom 'industry leaders' every day.
Again, I'm long. I've probably got more shares than most on this board and will be holding them because it's foolish to sell this low.
I'm long - my concern is that while CVSI has been doing a lot to position themselves as a market leader, they become too slow to adapt to online sales, catchy and sustaining marketing efforts and price points which eventually lets competitors surpass them with cheaper prices.
I don't necessarily think this will definitely happen, but this is a very dangerous time for CVSI.
It's an entirely plausible situation where FDA drags its feet and CVSI sales continue to tank b/c they are so expensive while a few smaller brands catch up in revenue that allows them to meet FDA guidelines when they come out and get some good deals with the bigs and CVSI is the 'walking dinosaur.'
Think Sears and JC Penney, but in this new industry. Relatively, CVSI is older, more established, but almost at this point seems to be letting competitors catch up somewhat.
This is a dangerous time for CVSI.
Sales and distribution is business warfare and just because CVSI is gaining big box contracts, does not mean other brands like Leaf Love won't get some, outperform due to the price point difference and eventually CVSI may have a shiny little image, but were asleep at the wheel while many competitors catch up.
THIS is the real danger. They MUST get online going MUCH faster and must re-focus their branding and marketing efforts, along with price point considerations.
I hope they are taking this strategically vulnerable position seriously.
Simply having a 'longer term outlook' and 'waiting it out for FDA' is not a winning strategy or before you know it, without realizing it, CVSI finds itself in an untenable situation. This happens all the time and industry players all of a sudden wake up and realize the playing field has changed, and they were too late to adjusting to it.
They must stay on offense and double down on their weaknesses and keep competitors at bay.
Agree this is completely dead money until FDA announces.
I'm waiting to accumulate some more and bring my average down. I'm in for a lot of money right now and down a lot but the sector is solid and the CVSI team seems to be responsible with their balance sheet to hold out until FDA regs.
Until then - they are just building credibility, governance and distribution deals to fill shelf space when FDA hits - then it's off to the races.
A company would be smart to try to buy CV now before FDA issues guidance. I'd be fine with $6, happy at $8, excited at $10 (but no way $10 happens).
After FDA CV gets a lot more expensive.
Shut up about politics. Let's keep politics off this board. No need to attack him with your political opinion when the board clearly doesn't want any political opinions on here.
This guy should be banned. This is a 100% clear lie to push a negative narrative on the company to affect stock price. This is illegal.
There is nothing out about this. Don't spread market manipulating illegal rumors here unless you can point to a source.